Sudarshan Chemical Industries (506655) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
9 Sep, 2026Executive summary
Achieved highest ever operative revenue and EBITDA in FY24, with sales growing at a 10% CAGR and operating profit at 11% CAGR since FY11.
Revenue and profitability saw strong year-over-year growth for both the quarter and half year ended 30th September 2024, with significant improvement in margins and net profit, driven by robust operational performance and one-time gains.
Pigment business remains the core focus, now the 3rd largest globally, with a domestic market share of 35% and exports to 85+ countries.
Announced acquisition of Heubach group assets, expanding global footprint and expected to be EBITDA and EPS accretive.
Board approved the unaudited financial results and limited review reports for both standalone and consolidated statements.
Financial highlights
Q2 FY25 consolidated income from operations rose 16% YoY to ₹696 Cr; EBITDA up 42% YoY to ₹94 Cr; PAT up 128% YoY to ₹41 Cr.
H1 FY25 consolidated income from operations up 10% YoY to ₹1,330 Cr; EBITDA up 30% YoY to ₹175 Cr; PAT up 79% YoY to ₹70 Cr.
Standalone revenue from operations for Q2 FY25 was ₹66,865.1 lakhs, up from ₹48,345.9 lakhs in Q2 FY24; consolidated revenue was ₹68,891.0 lakhs, up from ₹59,474.7 lakhs year-over-year.
Standalone net profit for Q2 FY25 was ₹6,124.7 lakhs, up from ₹1,413.7 lakhs in Q2 FY24; consolidated net profit was ₹2,990.4 lakhs, up from ₹1,785.9 lakhs.
Exceptional gain of ₹31,510.1 lakhs from sale of land in FY24, impacting year-to-date and prior period results.
Outlook and guidance
Capex program to drive future growth and EBITDA improvement, with focus on expanding specialty pigment portfolio and global competitiveness.
Integration of Heubach assets expected to close in Q1 CY2025, aiming for synergy capture and global leadership.
Board approved the acquisition of Heubach Group's global pigment business for €127.5 million (approx. ₹1,18,000 lakhs), expected to expand global footprint and product portfolio, subject to regulatory approvals.
Continued focus on sustainability, efficiency, and return on capital employed.
Latest events from Sudarshan Chemical Industries
- Revenue and margins rose, with normalized profit and improved financial strength.506655
Q1 24/25 - Acquisition creates a global pigment leader with 19 sites and accretive financials.506655M&A announcement
- Record revenue and profit growth in Q3/9M FY25, with strong pigment exports and acquisition-driven expansion.506655Q3 24/25
- Heubach acquisition drove strong revenue and EBITDA growth, but net profit declined on costs.506655Q4 24/25
- Q1 FY26 sales reached ₹2,507 Cr and EBITDA rose, but margins and net profit ratio declined.506655Q1 25/26
- Pigments-led growth and Heubach acquisition drove higher revenue, with integration costs impacting profit.506655Q2 25/26
- Revenue growth from acquisition offset by integration and regulatory costs, resulting in a net loss.506655Q3 25/26
- Record revenue and EBITDA growth achieved, with Heubach integration and debt reduction progressing.506655Q4 25/26
- Q1 FY27 saw robust revenue, profit, and EBITDA growth, with ongoing integration and restructuring.506655Q1 26/27